EA201792289A1 - Способы обнаружения агглютинации и композиции для их осуществления - Google Patents
Способы обнаружения агглютинации и композиции для их осуществленияInfo
- Publication number
- EA201792289A1 EA201792289A1 EA201792289A EA201792289A EA201792289A1 EA 201792289 A1 EA201792289 A1 EA 201792289A1 EA 201792289 A EA201792289 A EA 201792289A EA 201792289 A EA201792289 A EA 201792289A EA 201792289 A1 EA201792289 A1 EA 201792289A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- methods
- detecting
- antigen
- implementation
- agglutinations
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 6
- 239000000203 mixture Substances 0.000 title abstract 2
- 239000000427 antigen Substances 0.000 abstract 4
- 102000036639 antigens Human genes 0.000 abstract 4
- 108091007433 antigens Proteins 0.000 abstract 4
- 239000011230 binding agent Substances 0.000 abstract 2
- 238000001514 detection method Methods 0.000 abstract 2
- 102000040430 polynucleotide Human genes 0.000 abstract 2
- 108091033319 polynucleotide Proteins 0.000 abstract 2
- 239000002157 polynucleotide Substances 0.000 abstract 2
- 238000004220 aggregation Methods 0.000 abstract 1
- 230000002776 aggregation Effects 0.000 abstract 1
- 230000003321 amplification Effects 0.000 abstract 1
- 239000003153 chemical reaction reagent Substances 0.000 abstract 1
- 238000003199 nucleic acid amplification method Methods 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
- 150000007523 nucleic acids Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6804—Nucleic acid analysis using immunogens
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/686—Polymerase chain reaction [PCR]
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54306—Solid-phase reaction mechanisms
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/544—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being organic
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2525/00—Reactions involving modified oligonucleotides, nucleic acids, or nucleotides
- C12Q2525/10—Modifications characterised by
- C12Q2525/117—Modifications characterised by incorporating modified base
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2525/00—Reactions involving modified oligonucleotides, nucleic acids, or nucleotides
- C12Q2525/10—Modifications characterised by
- C12Q2525/155—Modifications characterised by incorporating/generating a new priming site
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2525/00—Reactions involving modified oligonucleotides, nucleic acids, or nucleotides
- C12Q2525/10—Modifications characterised by
- C12Q2525/197—Modifications characterised by incorporating a spacer/coupling moiety
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2531/00—Reactions of nucleic acids characterised by
- C12Q2531/10—Reactions of nucleic acids characterised by the purpose being amplify/increase the copy number of target nucleic acid
- C12Q2531/113—PCR
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Pathology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562149324P | 2015-04-17 | 2015-04-17 | |
| PCT/US2016/027906 WO2016168711A1 (en) | 2015-04-17 | 2016-04-15 | Methods for detecting agglutination and compositions for use in practicing the same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EA201792289A1 true EA201792289A1 (ru) | 2018-04-30 |
Family
ID=57127062
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EA201792289A EA201792289A1 (ru) | 2015-04-17 | 2016-04-15 | Способы обнаружения агглютинации и композиции для их осуществления |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US11149296B2 (enExample) |
| EP (2) | EP4123031A1 (enExample) |
| JP (1) | JP6822973B2 (enExample) |
| CN (1) | CN107614699A (enExample) |
| AU (1) | AU2016249392A1 (enExample) |
| BR (1) | BR112017022329A2 (enExample) |
| CA (1) | CA2982998A1 (enExample) |
| EA (1) | EA201792289A1 (enExample) |
| WO (1) | WO2016168711A1 (enExample) |
| ZA (1) | ZA201707114B (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106591436A (zh) * | 2016-11-24 | 2017-04-26 | 湖南大学 | 用于检测人体内低丰度抗体的邻位连接核酸探针与试剂盒及其制备方法 |
| CA3058451A1 (en) | 2017-03-30 | 2018-10-04 | The Board Of Trustees Of The Leland Stanford Junior University | Multiplex isotype-specific antibody detection |
| CN109142730B (zh) * | 2018-06-14 | 2021-04-23 | 郑州大学第一附属医院 | 一种肺癌标志物抗-psip1自身抗体及其应用 |
| JP7675441B2 (ja) * | 2019-05-06 | 2025-05-13 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | 移植拒絶反応の非ｈｌａマーカー |
| CN111323590B (zh) * | 2020-03-19 | 2022-04-22 | 福建省立医院 | 抗TIF1γ-IgA与抗TIF1γ-IgG作为联合诊断标志物在肺癌诊断中的应用 |
| CN111398584A (zh) * | 2020-03-20 | 2020-07-10 | 北京良芯生物科技发展有限公司 | 一种用于检测人类免疫缺陷病毒hiv1/2抗体的蛋白芯片及其制备方法 |
| CN111499724A (zh) * | 2020-04-15 | 2020-08-07 | 上海领潮生物新材料有限公司 | 一种s-腺苷同型半胱氨酸-鸡卵白蛋白偶联物的制备方法 |
| US20230152318A1 (en) * | 2020-04-24 | 2023-05-18 | Siemens Healthcare Diagnostics Inc. | Compositions, kits, and methods for anti-microbial serology assays using anti-human immunoglobulin antibody |
| US20230142838A1 (en) * | 2021-11-08 | 2023-05-11 | Summit Biolabs, Inc. | Devices and methods for nucleic acid extraction-free sti pathogen testing |
| CN114316016B (zh) * | 2021-12-14 | 2023-11-10 | 江苏浩欧博生物医药股份有限公司 | 一种Jo-1抗原生物素化的方法及抗Jo-1抗体检测试剂盒 |
| CN115060912B (zh) * | 2022-06-23 | 2024-02-02 | 南京浦光生物科技有限公司 | 检测目标抗体的试剂组合、试剂盒、检测系统及检测方法 |
| EP4389913A1 (en) * | 2022-12-23 | 2024-06-26 | Universität Heidelberg | A pcr-elisa analogous antibody-free method for detecting a target nucleic acid in a sample |
| CN116125076A (zh) * | 2022-12-30 | 2023-05-16 | 广州医科大学 | 检测桥粒蛋白的试剂在制备肝纤维化的检测产品中的应用 |
| CN118667920B (zh) * | 2024-07-30 | 2024-11-12 | 北京华诺奥美基因生物科技有限公司 | 一种基于微流控的低丰度生物标志物的检测试剂盒、检测方法及其应用 |
Family Cites Families (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4292403A (en) * | 1978-08-24 | 1981-09-29 | Akzona Incorporated | Detection and/or determination of IgM, IgA, IgD and IgE immunoglobulins |
| US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
| US4683195A (en) | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
| US4965188A (en) | 1986-08-22 | 1990-10-23 | Cetus Corporation | Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme |
| US4883867A (en) | 1985-11-01 | 1989-11-28 | Becton, Dickinson And Company | Detection of reticulocytes, RNA or DNA |
| US4800159A (en) | 1986-02-07 | 1989-01-24 | Cetus Corporation | Process for amplifying, detecting, and/or cloning nucleic acid sequences |
| CA2087724C (en) * | 1990-07-24 | 2003-09-16 | John J. Sninsky | Reduction of non-specific amplification during in vitro nucleic acid amplification using modified nucleic acid bases |
| ATE152831T1 (de) | 1991-09-16 | 1997-05-15 | Molecular Probes Inc | Dimere unsymmetrische cyaninfarbstoffe |
| US5321130A (en) | 1992-02-10 | 1994-06-14 | Molecular Probes, Inc. | Unsymmetrical cyanine dyes with a cationic side chain |
| WO1994007921A1 (en) | 1992-09-25 | 1994-04-14 | Commonwealth Scientific And Industrial Research Organisation | Target binding polypeptide |
| US5410030A (en) | 1993-04-05 | 1995-04-25 | Molecular Probes, Inc. | Dimers of unsymmetrical cyanine dyes containing pyridinium moieties |
| US5658751A (en) | 1993-04-13 | 1997-08-19 | Molecular Probes, Inc. | Substituted unsymmetrical cyanine dyes with selected permeability |
| US5436134A (en) | 1993-04-13 | 1995-07-25 | Molecular Probes, Inc. | Cyclic-substituted unsymmetrical cyanine dyes |
| US5512462A (en) | 1994-02-25 | 1996-04-30 | Hoffmann-La Roche Inc. | Methods and reagents for the polymerase chain reaction amplification of long DNA sequences |
| US20030104361A1 (en) | 1997-09-29 | 2003-06-05 | Susan Weininger | Method of detection of nucleic acids with a specific sequence composition |
| AUPO591797A0 (en) | 1997-03-27 | 1997-04-24 | Commonwealth Scientific And Industrial Research Organisation | High avidity polyvalent and polyspecific reagents |
| SE504798C2 (sv) * | 1995-06-16 | 1997-04-28 | Ulf Landegren | Immunanalys och testkit med två reagens som kan tvärbindas om de adsorberats till analyten |
| EP1006197A1 (en) * | 1998-12-04 | 2000-06-07 | Transgene S.A. | Use of an immuno complex for the preparation of a therapeutic composition useful for transfecting a polynucleotide into macropinocyte cells |
| SE516272C2 (sv) | 2000-02-18 | 2001-12-10 | Ulf Landegren | Metoder och kit för analytdetektion mha proximitets-probning |
| US6511809B2 (en) * | 2000-06-13 | 2003-01-28 | E. I. Du Pont De Nemours And Company | Method for the detection of an analyte by means of a nucleic acid reporter |
| EP1451356A1 (en) * | 2001-11-23 | 2004-09-01 | Simon Fredriksson | Method and kit for proximity probing with multivalent proximity probes |
| US7399590B2 (en) | 2002-02-21 | 2008-07-15 | Asm Scientific, Inc. | Recombinase polymerase amplification |
| CN101410530B (zh) | 2003-04-18 | 2013-03-27 | 贝克顿·迪金森公司 | 免疫-扩增 |
| US7198900B2 (en) | 2003-08-29 | 2007-04-03 | Applera Corporation | Multiplex detection compositions, methods, and kits |
| WO2005074417A2 (en) | 2003-09-03 | 2005-08-18 | Salk Institute For Biological Studies | Multiple antigen detection assays and reagents |
| US20070298432A1 (en) * | 2003-11-07 | 2007-12-27 | Hep-Genics Pty Ltd | Binding Assay Components |
| US7914987B2 (en) * | 2004-06-14 | 2011-03-29 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and compositions for use in analyte detection using proximity probes |
| JP5188808B2 (ja) * | 2004-11-03 | 2013-04-24 | アイリス モレキュラー ダイアグノスティクス， インコーポレイテッド | 同種の分析物検出 |
| US8673567B2 (en) | 2006-03-08 | 2014-03-18 | Atila Biosystems, Inc. | Method and kit for nucleic acid sequence detection |
| US20070281367A1 (en) * | 2006-05-03 | 2007-12-06 | Applera Corporation | Methods, Compositions, and Kits for Quantitating Antibodies |
| WO2008066483A1 (en) | 2006-11-27 | 2008-06-05 | Mohammad Alimohammadi | Use of nalp5 in methods for diagnosis and therapy of parathyroid related disorders |
| JP2010226986A (ja) * | 2009-03-26 | 2010-10-14 | Kaneka Corp | 抗原または抗体の検出方法 |
| WO2011062933A2 (en) | 2009-11-18 | 2011-05-26 | Raybiotech, Inc. | Array-based proximity ligation association assays |
| US8993347B2 (en) | 2009-12-17 | 2015-03-31 | Cornell University | Methods for detecting antibodies in mucosal samples and device for sampling mucosal material |
| GB201108678D0 (en) | 2011-05-24 | 2011-07-06 | Olink Ab | Multiplexed proximity ligation assay |
| US9823248B2 (en) | 2011-11-15 | 2017-11-21 | Erasmus University Medical Center Rotterdam | Methods and kits for detecting IgE-expressing B cells |
-
2016
- 2016-04-15 EP EP22177391.4A patent/EP4123031A1/en active Pending
- 2016-04-15 BR BR112017022329A patent/BR112017022329A2/pt not_active IP Right Cessation
- 2016-04-15 US US15/566,594 patent/US11149296B2/en active Active
- 2016-04-15 JP JP2017554311A patent/JP6822973B2/ja active Active
- 2016-04-15 CN CN201680031621.3A patent/CN107614699A/zh active Pending
- 2016-04-15 WO PCT/US2016/027906 patent/WO2016168711A1/en not_active Ceased
- 2016-04-15 CA CA2982998A patent/CA2982998A1/en not_active Abandoned
- 2016-04-15 EA EA201792289A patent/EA201792289A1/ru unknown
- 2016-04-15 EP EP16780915.1A patent/EP3283638B1/en active Active
- 2016-04-15 AU AU2016249392A patent/AU2016249392A1/en not_active Abandoned
-
2017
- 2017-10-19 ZA ZA2017/07114A patent/ZA201707114B/en unknown
-
2021
- 2021-09-14 US US17/474,424 patent/US12054768B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP3283638A1 (en) | 2018-02-21 |
| EP3283638A4 (en) | 2018-09-12 |
| JP6822973B2 (ja) | 2021-01-27 |
| WO2016168711A1 (en) | 2016-10-20 |
| US11149296B2 (en) | 2021-10-19 |
| JP2018512862A (ja) | 2018-05-24 |
| US20210403978A1 (en) | 2021-12-30 |
| US20180100181A1 (en) | 2018-04-12 |
| CA2982998A1 (en) | 2016-10-20 |
| ZA201707114B (en) | 2019-02-27 |
| EP4123031A1 (en) | 2023-01-25 |
| BR112017022329A2 (pt) | 2018-07-17 |
| CN107614699A (zh) | 2018-01-19 |
| EP3283638B1 (en) | 2022-06-08 |
| AU2016249392A1 (en) | 2017-11-16 |
| US12054768B2 (en) | 2024-08-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA201792289A1 (ru) | Способы обнаружения агглютинации и композиции для их осуществления | |
| MX2020009021A (es) | Ensayos para detectar la presencia o la cantidad de un anticuerpo antifarmaco. | |
| BR112016027475A2 (pt) | kit, dispositivo e método para a detecção de câncer pancreático | |
| BR112017011326A2 (pt) | anticorpo, ácido nucleico, vetor, célula hospedeira, método para produzir o anticorpo, imunoconjugado, composição farmacêutica, usos do anticorpo, métodos para tratar ou retardar a progressão de distúrbio proliferativo celular e para intensificar a função imune | |
| CA2951016C (en) | Prostate cancer detection kit or device, and detection method | |
| BR112017009728A2 (pt) | anticorpos isolados, ácido nucleico isolado, vetor, célula hospedeira, método para produzir o anticorpo, composição, usos de um anticorpo e métodos de tratamento de um distúrbio | |
| BR112016014022A2 (pt) | anticorpos anti-cd3, ácido nucleico isolado, vetor, célula hospedeira, método de produção do anticorpo anti-cd3, imunoconjugado, composição, uso do anticorpo anti-cd3, métodos de tratamento, métodos de intensificação da função imune e kit | |
| EA201692157A1 (ru) | Синтез двухцепочечных нуклеиновых кислот | |
| MX362075B (es) | Ensayo de combinación de antígeno-anticuerpo del virus de la hepatitis c (vhc) y métodos y composiciones para usarlo. | |
| BR112015022260A2 (pt) | anticorpo monoclonal, polinucleotídeo, composição farmacêutica, fragmento isolado de tau, uso de um anticorpo, método de triagem de um agente e ácido nucleico | |
| CA3210980C (en) | Stomach cancer detection kit or device, and detection method | |
| EA201690731A1 (ru) | Анализ igfbp7, имеющий улучшенную характеристику в биологических образцах | |
| MX2016001573A (es) | Ensayos para timp2 con mejor rendimiento en muestras biológicas. | |
| EA201892325A1 (ru) | Композиции и способы детектирования белков клетки-хозяина | |
| EA201891002A1 (ru) | Иммунологический анализ для определения расщепленного высокомолекулярного кининогена | |
| EA201991506A1 (ru) | Системы и способы для тестирования и скрининга с использованием связанных с соединениями субстратов | |
| MX377788B (es) | Composiciones y metodos para la deteccion y analisis de tuberculosis micobacteriana. | |
| MX2019000591A (es) | Tira mejorada de ensayo de analisis de orina de bajo volumen de muestra, kits analiticos y metodos de uso relacionados con la misma. | |
| HK1254818A1 (zh) | 抗原肽及其用於诊断和治疗自闭症的用途 | |
| WO2015200833A3 (en) | COMPOSITIONS AND METHODS FOR DETECTING HUMAN PEGIVIRUS 2 (HPgV-2) | |
| EP4253950A3 (en) | Ce-western applications for antibody development | |
| GB2541596A (en) | Method and composition for determining specific antibody responses to species of filovirus | |
| WO2015153949A3 (en) | Compositions and methods for identifying ehrlichia species | |
| MX386012B (es) | Dispositivo y metodo para detectar antigenos de grupo sanguineo por medio de un anticuerpo incompleto. | |
| MX2016017048A (es) | Inmunoensayo reactivo y colaborativo potenciado por enzimas (ceer) usando citometria de flujo. |